fanta.bio Sample: CNhs11977
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
16632 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1171 / 13366 (8.8%) | 354 / 133660 (0.3%) | −324.0 | −324.0 | 33.08 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1710 / 13366 (12.8%) | 624 / 133660 (0.5%) | −324.0 | −324.0 | 27.40 |
| HIF1A SRX11007095 | HK-2 Kidney | 2037 / 13366 (15.2%) | 789 / 133660 (0.6%) | −324.0 | −324.0 | 25.82 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1536 / 13366 (11.5%) | 689 / 133660 (0.5%) | −324.0 | −324.0 | 22.29 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2156 / 13366 (16.1%) | 1025 / 133660 (0.8%) | −324.0 | −324.0 | 21.03 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2073 / 13366 (15.5%) | 1000 / 133660 (0.7%) | −324.0 | −324.0 | 20.73 |
| SCML2 SRX644728 | 293 Kidney | 1307 / 13366 (9.8%) | 643 / 133660 (0.5%) | −324.0 | −324.0 | 20.33 |
| FOXP1 SRX736067 | LNCAP Prostate | 1666 / 13366 (12.5%) | 981 / 133660 (0.7%) | −324.0 | −324.0 | 16.98 |
| MYH11 SRX265221 | ME-1 Blood | 766 / 13366 (5.7%) | 529 / 133660 (0.4%) | −324.0 | −324.0 | 14.48 |
| MED1 SRX9419945 | BT-474 Breast | 3297 / 13366 (24.7%) | 2316 / 133660 (1.7%) | −324.0 | −324.0 | 14.24 |
| BRD4 SRX9419935 | BT-474 Breast | 3289 / 13366 (24.6%) | 2320 / 133660 (1.7%) | −324.0 | −324.0 | 14.18 |
| MED1 SRX9419944 | BT-474 Breast | 3228 / 13366 (24.2%) | 2283 / 133660 (1.7%) | −324.0 | −324.0 | 14.14 |
| BRD4 SRX9419937 | BT-474 Breast | 3240 / 13366 (24.2%) | 2368 / 133660 (1.8%) | −324.0 | −324.0 | 13.68 |
| MED1 SRX9419946 | BT-474 Breast | 3349 / 13366 (25.1%) | 2472 / 133660 (1.8%) | −324.0 | −324.0 | 13.55 |
| MED1 SRX9419947 | BT-474 Breast | 3249 / 13366 (24.3%) | 2401 / 133660 (1.8%) | −324.0 | −324.0 | 13.53 |
| BRD4 SRX9419936 | BT-474 Breast | 3331 / 13366 (24.9%) | 2464 / 133660 (1.8%) | −324.0 | −324.0 | 13.52 |
| BRD4 SRX9419938 | BT-474 Breast | 3307 / 13366 (24.7%) | 2463 / 133660 (1.8%) | −324.0 | −324.0 | 13.43 |
| EZH2 SRX2146136 | LNCAP Prostate | 7176 / 13366 (53.7%) | 6703 / 133660 (5.0%) | −324.0 | −324.0 | 10.71 |
| BRD4 SRX736201 | 90-8TL Neural | 5489 / 13366 (41.1%) | 5402 / 133660 (4.0%) | −324.0 | −324.0 | 10.16 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 773 / 13366 (5.8%) | 761 / 133660 (0.6%) | −324.0 | −324.0 | 10.16 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1514 / 13366 (11.3%) | 2257 / 133660 (1.7%) | −324.0 | −324.0 | 6.71 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1543 / 13366 (11.5%) | 4030 / 133660 (3.0%) | −324.0 | −324.0 | 3.83 |
| Epitope tags SRX10549776 | K-562 Blood | 1531 / 13366 (11.5%) | 4000 / 133660 (3.0%) | −324.0 | −324.0 | 3.83 |
| AGO2 SRX4708039 | Hep G2 Liver | 2006 / 13366 (15.0%) | 5899 / 133660 (4.4%) | −324.0 | −324.0 | 3.40 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2102 / 13366 (15.7%) | 7624 / 133660 (5.7%) | −324.0 | −324.0 | 2.76 |
| 5-mC SRX882965 | LNCAP Prostate | 2492 / 13366 (18.6%) | 9239 / 133660 (6.9%) | −324.0 | −324.0 | 2.70 |
| 5-mC SRX882970 | LNCAP Prostate | 3056 / 13366 (22.9%) | 11924 / 133660 (8.9%) | −324.0 | −324.0 | 2.56 |
| 5-mC SRX882968 | LNCAP Prostate | 2993 / 13366 (22.4%) | 11847 / 133660 (8.9%) | −324.0 | −324.0 | 2.53 |
| RUNX1 SRX2513054 | 293 Kidney | 3238 / 13366 (24.2%) | 13956 / 133660 (10.4%) | −324.0 | −324.0 | 2.32 |
| PBX4 SRX2731658 | PC-3 Prostate | 543 / 13366 (4.1%) | 20966 / 133660 (15.7%) | −324.0 | −324.0 | 0.26 |
| TP53 SRX19538279 | Osteoblasts Bone | 480 / 13366 (3.6%) | 240 / 133660 (0.2%) | −315.4 | −312.3 | 20.00 |
| CIC SRX13262055 | Astrocytes Neural | 2892 / 13366 (21.6%) | 13245 / 133660 (9.9%) | −308.7 | −305.6 | 2.18 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 587 / 13366 (4.4%) | 513 / 133660 (0.4%) | −308.4 | −305.4 | 11.44 |
| HIF1A SRX20663235 | HK-2 Kidney | 453 / 13366 (3.4%) | 215 / 133660 (0.2%) | −302.6 | −299.6 | 21.07 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1207 / 13366 (9.0%) | 2993 / 133660 (2.2%) | −301.3 | −298.3 | 4.03 |
| YAP1 SRX757325 | H2052 Lung | 411 / 13366 (3.1%) | 16194 / 133660 (12.1%) | −286.8 | −283.8 | 0.25 |
| FOS SRX150477 | MCF 10A Breast | 386 / 13366 (2.9%) | 15730 / 133660 (11.8%) | −285.9 | −283.0 | 0.25 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 556 / 13366 (4.2%) | 533 / 133660 (0.4%) | −278.7 | −275.8 | 10.43 |
| TP53 SRX19538274 | U2OS Bone | 384 / 13366 (2.9%) | 156 / 133660 (0.1%) | −268.8 | −265.9 | 24.62 |
| TP53 SRX19538268 | U2OS Bone | 383 / 13366 (2.9%) | 156 / 133660 (0.1%) | −267.9 | −265.0 | 24.55 |
| FOS SRX150478 | MCF 10A Breast | 438 / 13366 (3.3%) | 16083 / 133660 (12.0%) | −267.1 | −264.2 | 0.27 |
| YAP1 SRX757326 | H2052 Lung | 346 / 13366 (2.6%) | 14453 / 133660 (10.8%) | −266.3 | −263.5 | 0.24 |
| AGO2 SRX6783958 | Hep G2 Liver | 1229 / 13366 (9.2%) | 3472 / 133660 (2.6%) | −264.4 | −261.5 | 3.54 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1691 / 13366 (12.7%) | 6128 / 133660 (4.6%) | −261.9 | −259.0 | 2.76 |
| TP53 SRX19538276 | U2OS Bone | 381 / 13366 (2.9%) | 165 / 133660 (0.1%) | −261.7 | −258.8 | 23.09 |
| FOXA1 SRX4815198 | MCF-7 Breast | 642 / 13366 (4.8%) | 19119 / 133660 (14.3%) | −258.3 | −255.4 | 0.34 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 595 / 13366 (4.5%) | 745 / 133660 (0.6%) | −256.4 | −253.6 | 7.99 |
| TRP47 SRX4548329 | THP-1 Blood | 2407 / 13366 (18.0%) | 11037 / 133660 (8.3%) | −249.7 | −246.9 | 2.18 |
| FOXA1 SRX4815197 | MCF-7 Breast | 449 / 13366 (3.4%) | 15721 / 133660 (11.8%) | −248.9 | −246.1 | 0.29 |
| TP53 SRX19538267 | U2OS Bone | 353 / 13366 (2.6%) | 141 / 133660 (0.1%) | −248.2 | −245.4 | 25.04 |
| TP53 SRX19538281 | Osteoblasts Bone | 403 / 13366 (3.0%) | 242 / 133660 (0.2%) | −248.0 | −245.1 | 16.65 |
| TP53 SRX19538280 | Osteoblasts Bone | 376 / 13366 (2.8%) | 191 / 133660 (0.1%) | −245.5 | −242.7 | 19.69 |
| TP53 SRX19538273 | U2OS Bone | 346 / 13366 (2.6%) | 140 / 133660 (0.1%) | −242.4 | −239.6 | 24.71 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 378 / 13366 (2.8%) | 203 / 133660 (0.2%) | −242.1 | −239.3 | 18.62 |
| BRD1 SRX286203 | RKO Digestive tract | 1141 / 13366 (8.5%) | 3256 / 133660 (2.4%) | −241.7 | −238.9 | 3.50 |
| AGO2 SRX6783957 | Hep G2 Liver | 1208 / 13366 (9.0%) | 3636 / 133660 (2.7%) | −239.7 | −237.0 | 3.32 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 417 / 13366 (3.1%) | 14856 / 133660 (11.1%) | −238.2 | −235.4 | 0.28 |
| KAT7 SRX101303 | RKO Digestive tract | 1278 / 13366 (9.6%) | 4050 / 133660 (3.0%) | −237.4 | −234.6 | 3.16 |
| FOS SRX4192880 | MCF 10A Breast | 301 / 13366 (2.3%) | 12729 / 133660 (9.5%) | −234.9 | −232.1 | 0.24 |
| SREBF2 SRX5359048 | HCC70 Breast | 1595 / 13366 (11.9%) | 5991 / 133660 (4.5%) | −232.1 | −229.3 | 2.66 |
| FOXA1 SRX176862 | MCF-7 Breast | 211 / 13366 (1.6%) | 10942 / 133660 (8.2%) | −231.7 | −229.0 | 0.19 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1705 / 13366 (12.8%) | 6688 / 133660 (5.0%) | −231.5 | −228.7 | 2.55 |
| TP53 SRX19538269 | U2OS Bone | 423 / 13366 (3.2%) | 352 / 133660 (0.3%) | −226.9 | −224.2 | 12.02 |
| TP53 SRX19538275 | U2OS Bone | 338 / 13366 (2.5%) | 158 / 133660 (0.1%) | −226.7 | −224.0 | 21.39 |
| BRPF3 SRX796085 | RKO Digestive tract | 1029 / 13366 (7.7%) | 2849 / 133660 (2.1%) | −225.3 | −222.6 | 3.61 |
| FOXA1 SRX3931044 | MCF-7 Breast | 416 / 13366 (3.1%) | 14426 / 133660 (10.8%) | −224.6 | −221.9 | 0.29 |
| BMI1 SRX7196721 | SF8628 Neural | 1602 / 13366 (12.0%) | 6190 / 133660 (4.6%) | −222.2 | −219.5 | 2.59 |
| FOXA1 SRX176863 | MCF-7 Breast | 200 / 13366 (1.5%) | 10449 / 133660 (7.8%) | −221.8 | −219.1 | 0.19 |
| TP53 SRX19538270 | U2OS Bone | 407 / 13366 (3.0%) | 328 / 133660 (0.2%) | −221.6 | −218.9 | 12.41 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1526 / 13366 (11.4%) | 5749 / 133660 (4.3%) | −220.3 | −217.7 | 2.65 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 490 / 13366 (3.7%) | 15455 / 133660 (11.6%) | −218.8 | −216.1 | 0.32 |
| BRPF3 SRX796084 | RKO Digestive tract | 1374 / 13366 (10.3%) | 4856 / 133660 (3.6%) | −218.5 | −215.8 | 2.83 |
| SS18 SRX3468047 | Fibroblasts Others | 528 / 13366 (4.0%) | 15894 / 133660 (11.9%) | −213.5 | −210.9 | 0.33 |
| MECOM SRX23677884 | HNT-34 Blood | 1601 / 13366 (12.0%) | 6330 / 133660 (4.7%) | −213.4 | −210.7 | 2.53 |
| GATA3 SRX190239 | MCF-7 Breast | 271 / 13366 (2.0%) | 11500 / 133660 (8.6%) | −211.4 | −208.7 | 0.24 |
| MECOM SRX23677885 | HNT-34 Blood | 1617 / 13366 (12.1%) | 6469 / 133660 (4.8%) | −211.1 | −208.4 | 2.50 |
| BRPF3 SRX796086 | RKO Digestive tract | 1309 / 13366 (9.8%) | 4595 / 133660 (3.4%) | −209.8 | −207.2 | 2.85 |
| GATA3 SRX190194 | SK-N-SH Neural | 499 / 13366 (3.7%) | 15273 / 133660 (11.4%) | −208.7 | −206.0 | 0.33 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1257 / 13366 (9.4%) | 4317 / 133660 (3.2%) | −207.9 | −205.2 | 2.91 |
| FOS SRX150517 | MCF 10A Breast | 343 / 13366 (2.6%) | 12669 / 133660 (9.5%) | −207.8 | −205.2 | 0.27 |
| MITF SRX1555436 | 501A Epidermis | 1764 / 13366 (13.2%) | 7494 / 133660 (5.6%) | −207.3 | −204.7 | 2.35 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1735 / 13366 (13.0%) | 7315 / 133660 (5.5%) | −206.7 | −204.1 | 2.37 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 528 / 13366 (4.0%) | 773 / 133660 (0.6%) | −204.9 | −202.3 | 6.83 |
| FOXA1 SRX1161177 | MCF-7 Breast | 170 / 13366 (1.3%) | 9369 / 133660 (7.0%) | −204.7 | −202.1 | 0.18 |
| MECOM SRX23677897 | HNT-34 Blood | 1843 / 13366 (13.8%) | 8082 / 133660 (6.0%) | −204.2 | −201.7 | 2.28 |
| MECOM SRX23677896 | HNT-34 Blood | 1898 / 13366 (14.2%) | 8469 / 133660 (6.3%) | −203.5 | −200.9 | 2.24 |
| FOXA1 SRX371482 | MCF-7 Breast | 282 / 13366 (2.1%) | 11456 / 133660 (8.6%) | −203.1 | −200.6 | 0.25 |
| Epitope tags SRX10549778 | K-562 Blood | 1053 / 13366 (7.9%) | 3226 / 133660 (2.4%) | −203.1 | −200.5 | 3.26 |
| RUNX1 SRX2014504 | Jurkat Blood | 2125 / 13366 (15.9%) | 10077 / 133660 (7.5%) | −201.9 | −199.4 | 2.11 |
| IRF3 SRX11453858 | Hep G2 Liver | 256 / 13366 (1.9%) | 68 / 133660 (0.1%) | −199.3 | −196.7 | 37.65 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 784 / 13366 (5.9%) | 19217 / 133660 (14.4%) | −198.3 | −195.7 | 0.41 |
| TP53 SRX19538282 | Osteoblasts Bone | 349 / 13366 (2.6%) | 256 / 133660 (0.2%) | −198.0 | −195.5 | 13.63 |
| RBFOX2 SRX4708082 | K-562 Blood | 2081 / 13366 (15.6%) | 9894 / 133660 (7.4%) | −196.0 | −193.5 | 2.10 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 123 / 13366 (0.9%) | 8142 / 133660 (6.1%) | −195.7 | −193.2 | 0.15 |
| TCF12 SRX190356 | SK-N-SH Neural | 620 / 13366 (4.6%) | 16672 / 133660 (12.5%) | −194.5 | −191.9 | 0.37 |
| FOXA1 SRX371483 | MCF-7 Breast | 216 / 13366 (1.6%) | 9978 / 133660 (7.5%) | −194.4 | −191.8 | 0.22 |
| SMARCA2 SRX8119677 | MeT-5A Others | 345 / 13366 (2.6%) | 12256 / 133660 (9.2%) | −193.3 | −190.8 | 0.28 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1679 / 13366 (12.6%) | 7199 / 133660 (5.4%) | −193.0 | −190.5 | 2.33 |
| FOS SRX150476 | MCF 10A Breast | 374 / 13366 (2.8%) | 12732 / 133660 (9.5%) | −192.8 | −190.3 | 0.29 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1411 / 13366 (10.6%) | 5482 / 133660 (4.1%) | −192.4 | −189.9 | 2.57 |
| YAP1 SRX5718140 | 293 Kidney | 353 / 13366 (2.6%) | 12355 / 133660 (9.2%) | −192.2 | −189.6 | 0.29 |
| EP300 SRX2671813 | Fibroblasts Others | 134 / 13366 (1.0%) | 8257 / 133660 (6.2%) | −191.3 | −188.8 | 0.16 |
| FOXA1 SRX1161173 | MCF-7 Breast | 133 / 13366 (1.0%) | 8234 / 133660 (6.2%) | −191.3 | −188.8 | 0.16 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 515 / 13366 (3.9%) | 14928 / 133660 (11.2%) | −190.4 | −187.9 | 0.34 |
| LEO1 SRX1873456 | SEM Blood | 1300 / 13366 (9.7%) | 4829 / 133660 (3.6%) | −190.4 | −187.9 | 2.69 |
| ESR1 SRX371478 | MCF-7 Breast | 263 / 13366 (2.0%) | 10716 / 133660 (8.0%) | −189.8 | −187.3 | 0.25 |
| BRD4 SRX736204 | 90-8TL Neural | 834 / 13366 (6.2%) | 2244 / 133660 (1.7%) | −187.8 | −185.3 | 3.72 |
| ESR1 SRX7624157 | MCF-7 Breast | 599 / 13366 (4.5%) | 16123 / 133660 (12.1%) | −187.8 | −185.3 | 0.37 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 426 / 13366 (3.2%) | 13421 / 133660 (10.0%) | −187.7 | −185.2 | 0.32 |
| FOXA1 SRX1161176 | MCF-7 Breast | 179 / 13366 (1.3%) | 9047 / 133660 (6.8%) | −186.8 | −184.3 | 0.20 |
| CEBPB SRX150632 | HeLa Uterus | 516 / 13366 (3.9%) | 14814 / 133660 (11.1%) | −186.6 | −184.1 | 0.35 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 304 / 13366 (2.3%) | 11338 / 133660 (8.5%) | −186.3 | −183.9 | 0.27 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 804 / 13366 (6.0%) | 19062 / 133660 (14.3%) | −186.0 | −183.6 | 0.42 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 496 / 13366 (3.7%) | 14473 / 133660 (10.8%) | −185.8 | −183.3 | 0.34 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 546 / 13366 (4.1%) | 15249 / 133660 (11.4%) | −185.7 | −183.3 | 0.36 |
| ING5 SRX286202 | RKO Digestive tract | 1162 / 13366 (8.7%) | 4079 / 133660 (3.1%) | −185.2 | −182.7 | 2.85 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1604 / 13366 (12.0%) | 6857 / 133660 (5.1%) | −184.9 | −182.4 | 2.34 |
| FOXA1 SRX371481 | MCF-7 Breast | 211 / 13366 (1.6%) | 9583 / 133660 (7.2%) | −184.0 | −181.6 | 0.22 |
| TLE3 SRX4815191 | MCF-7 Breast | 189 / 13366 (1.4%) | 9156 / 133660 (6.9%) | −183.6 | −181.2 | 0.21 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1666 / 13366 (12.5%) | 7303 / 133660 (5.5%) | −183.2 | −180.8 | 2.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 245 / 13366 (1.8%) | 10185 / 133660 (7.6%) | −183.0 | −180.6 | 0.24 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1576 / 13366 (11.8%) | 6715 / 133660 (5.0%) | −182.6 | −180.2 | 2.35 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1571 / 13366 (11.8%) | 6704 / 133660 (5.0%) | −181.4 | −179.0 | 2.34 |
| GATA3 SRX176864 | MCF-7 Breast | 124 / 13366 (0.9%) | 7765 / 133660 (5.8%) | −181.2 | −178.8 | 0.16 |
| ESR1 SRX4367193 | MCF-7 Breast | 791 / 13366 (5.9%) | 18677 / 133660 (14.0%) | −180.6 | −178.2 | 0.42 |
| FOS SRX4192879 | MCF 10A Breast | 235 / 13366 (1.8%) | 9933 / 133660 (7.4%) | −180.6 | −178.2 | 0.24 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 386 / 13366 (2.9%) | 12539 / 133660 (9.4%) | −180.6 | −178.2 | 0.31 |
| JUN SRX17561461 | LPS141 Adipocyte | 313 / 13366 (2.3%) | 11310 / 133660 (8.5%) | −180.4 | −178.0 | 0.28 |
| VGLL1 SRX24602130 | BT-20 Breast | 208 / 13366 (1.6%) | 9422 / 133660 (7.0%) | −180.3 | −177.9 | 0.22 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 245 / 13366 (1.8%) | 10102 / 133660 (7.6%) | −180.3 | −177.9 | 0.24 |
| ESR1 SRX371471 | ZR-75-1 Breast | 224 / 13366 (1.7%) | 9717 / 133660 (7.3%) | −180.1 | −177.7 | 0.23 |
| TP53 SRX19538271 | U2OS Bone | 550 / 13366 (4.1%) | 1008 / 133660 (0.8%) | −179.8 | −177.4 | 5.46 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 323 / 13366 (2.4%) | 11449 / 133660 (8.6%) | −179.4 | −177.1 | 0.28 |
| FOXA1 SRX1787653 | MCF-7 Breast | 143 / 13366 (1.1%) | 8105 / 133660 (6.1%) | −179.0 | −176.6 | 0.18 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 579 / 13366 (4.3%) | 15513 / 133660 (11.6%) | −178.8 | −176.4 | 0.37 |
| FOXA1 SRX1161175 | MCF-7 Breast | 134 / 13366 (1.0%) | 7911 / 133660 (5.9%) | −178.6 | −176.3 | 0.17 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 596 / 13366 (4.5%) | 15750 / 133660 (11.8%) | −178.3 | −175.9 | 0.38 |
| FOXA1 SRX100454 | T-47D Breast | 280 / 13366 (2.1%) | 10661 / 133660 (8.0%) | −178.0 | −175.6 | 0.26 |
| ESR1 SRX371469 | MCF-7 Breast | 216 / 13366 (1.6%) | 9493 / 133660 (7.1%) | −177.7 | −175.3 | 0.23 |
| AR SRX1067071 | LHSAR Prostate | 469 / 13366 (3.5%) | 13762 / 133660 (10.3%) | −177.1 | −174.8 | 0.34 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 366 / 13366 (2.7%) | 12098 / 133660 (9.1%) | −177.1 | −174.8 | 0.30 |
| AR SRX10820653 | LNCAP Prostate | 293 / 13366 (2.2%) | 185 / 133660 (0.1%) | −176.8 | −174.4 | 15.84 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 179 / 13366 (1.3%) | 8758 / 133660 (6.6%) | −176.7 | −174.4 | 0.20 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 174 / 13366 (1.3%) | 8655 / 133660 (6.5%) | −176.4 | −174.1 | 0.20 |
| JUN SRX4192884 | MCF 10A Breast | 157 / 13366 (1.2%) | 8308 / 133660 (6.2%) | −176.1 | −173.8 | 0.19 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 265 / 13366 (2.0%) | 10328 / 133660 (7.7%) | −175.9 | −173.5 | 0.26 |
| ESR1 SRX7624156 | MCF-7 Breast | 364 / 13366 (2.7%) | 12016 / 133660 (9.0%) | −175.6 | −173.2 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 502 / 13366 (3.8%) | 14213 / 133660 (10.6%) | −175.2 | −172.8 | 0.35 |
| GATA3 SRX5057632 | MCF-7 Breast | 108 / 13366 (0.8%) | 7254 / 133660 (5.4%) | −175.1 | −172.8 | 0.15 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1498 / 13366 (11.2%) | 6349 / 133660 (4.8%) | −174.9 | −172.5 | 2.36 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 566 / 13366 (4.2%) | 1110 / 133660 (0.8%) | −174.6 | −172.3 | 5.10 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 196 / 13366 (1.5%) | 9014 / 133660 (6.7%) | −174.1 | −171.8 | 0.22 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 239 / 13366 (1.8%) | 86 / 133660 (0.1%) | −173.0 | −170.6 | 27.79 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 283 / 13366 (2.1%) | 10556 / 133660 (7.9%) | −172.9 | −170.5 | 0.27 |
| ESR1 SRX371476 | MCF-7 Breast | 140 / 13366 (1.0%) | 7862 / 133660 (5.9%) | −172.5 | −170.1 | 0.18 |
| ESR1 SRX20282961 | MCF-7 Breast | 284 / 13366 (2.1%) | 10558 / 133660 (7.9%) | −172.4 | −170.1 | 0.27 |
| JUNB SRX8488088 | SUM 229PE Breast | 462 / 13366 (3.5%) | 13490 / 133660 (10.1%) | −172.3 | −170.0 | 0.34 |
| FOXL2 SRX6957431 | KGN Gonad | 553 / 13366 (4.1%) | 14895 / 133660 (11.1%) | −172.3 | −170.0 | 0.37 |
| MEAF6 DRX234811 | 293 Kidney | 1433 / 13366 (10.7%) | 5972 / 133660 (4.5%) | −172.2 | −169.9 | 2.40 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 284 / 13366 (2.1%) | 10548 / 133660 (7.9%) | −172.1 | −169.8 | 0.27 |
| ERG SRX063922 | K-562 Blood | 1376 / 13366 (10.3%) | 5612 / 133660 (4.2%) | −171.8 | −169.5 | 2.45 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 206 / 13366 (1.5%) | 9117 / 133660 (6.8%) | −171.3 | −169.0 | 0.23 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 296 / 13366 (2.2%) | 10728 / 133660 (8.0%) | −171.1 | −168.8 | 0.28 |
| FOXA1 SRX371480 | MCF-7 Breast | 124 / 13366 (0.9%) | 7480 / 133660 (5.6%) | −170.7 | −168.4 | 0.17 |
| JUN SRX6582171 | GM07492 Others | 463 / 13366 (3.5%) | 13441 / 133660 (10.1%) | −170.5 | −168.2 | 0.34 |
| RAC1 SRX10365541 | MCF-7 Breast | 81 / 13366 (0.6%) | 6515 / 133660 (4.9%) | −170.3 | −168.0 | 0.12 |
| FOXA1 SRX11222441 | MCF-7 Breast | 145 / 13366 (1.1%) | 7896 / 133660 (5.9%) | −170.0 | −167.7 | 0.18 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 336 / 13366 (2.5%) | 11372 / 133660 (8.5%) | −170.0 | −167.7 | 0.30 |
| Epitope tags SRX10549777 | K-562 Blood | 2071 / 13366 (15.5%) | 10435 / 133660 (7.8%) | −169.9 | −167.6 | 1.98 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 186 / 13366 (1.4%) | 8684 / 133660 (6.5%) | −169.4 | −167.1 | 0.21 |
| ESR1 SRX371470 | ZR-75-1 Breast | 193 / 13366 (1.4%) | 8812 / 133660 (6.6%) | −169.2 | −167.0 | 0.22 |
| ESR1 SRX371479 | MCF-7 Breast | 198 / 13366 (1.5%) | 8880 / 133660 (6.6%) | −168.3 | −166.1 | 0.22 |
| JUNB SRX8488073 | SUM 229PE Breast | 456 / 13366 (3.4%) | 13237 / 133660 (9.9%) | −167.6 | −165.4 | 0.34 |
| Epitope tags SRX2255894 | 293 Kidney | 1185 / 13366 (8.9%) | 4483 / 133660 (3.4%) | −167.6 | −165.3 | 2.64 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 811 / 13366 (6.1%) | 18468 / 133660 (13.8%) | −167.4 | −165.1 | 0.44 |
| FOXA1 SRX3923514 | MCF-7 Breast | 220 / 13366 (1.6%) | 9258 / 133660 (6.9%) | −167.3 | −165.0 | 0.24 |
| EP300 SRX150579 | HeLa Uterus | 118 / 13366 (0.9%) | 7255 / 133660 (5.4%) | −167.2 | −164.9 | 0.16 |
| IRF3 SRX11453861 | Hep G2 Liver | 223 / 13366 (1.7%) | 70 / 133660 (0.1%) | −167.1 | −164.8 | 31.86 |
| FOXA1 SRX11222437 | MCF-7 Breast | 136 / 13366 (1.0%) | 7614 / 133660 (5.7%) | −166.5 | −164.3 | 0.18 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 298 / 13366 (2.2%) | 10617 / 133660 (7.9%) | −166.4 | −164.2 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 154 / 13366 (1.2%) | 7971 / 133660 (6.0%) | −166.4 | −164.1 | 0.19 |
| FOXA1 SRX3931043 | MCF-7 Breast | 213 / 13366 (1.6%) | 9089 / 133660 (6.8%) | −165.9 | −163.7 | 0.23 |
| FOXA1 SRX1161174 | MCF-7 Breast | 222 / 13366 (1.7%) | 9250 / 133660 (6.9%) | −165.8 | −163.5 | 0.24 |
| MEAF6 DRX300417 | 293 Kidney | 1316 / 13366 (9.8%) | 5335 / 133660 (4.0%) | −165.7 | −163.4 | 2.47 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1225 / 13366 (9.2%) | 4765 / 133660 (3.6%) | −165.5 | −163.2 | 2.57 |
| WWTR1 SRX10119367 | MCF 10A Breast | 257 / 13366 (1.9%) | 9861 / 133660 (7.4%) | −165.2 | −163.0 | 0.26 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 238 / 13366 (1.8%) | 9488 / 133660 (7.1%) | −164.0 | −161.7 | 0.25 |
| SMARCA4 SRX5212366 | Mel270 Others | 310 / 13366 (2.3%) | 10713 / 133660 (8.0%) | −163.1 | −160.9 | 0.29 |
| ESR1 SRX194572 | MCF-7 Breast | 122 / 13366 (0.9%) | 7217 / 133660 (5.4%) | −162.9 | −160.6 | 0.17 |
| YAP1 SRX10119364 | MCF 10A Breast | 169 / 13366 (1.3%) | 8161 / 133660 (6.1%) | −162.7 | −160.5 | 0.21 |
| RAC1 SRX10365543 | MCF-7 Breast | 88 / 13366 (0.7%) | 6474 / 133660 (4.8%) | −162.6 | −160.4 | 0.14 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 138 / 13366 (1.0%) | 7538 / 133660 (5.6%) | −162.4 | −160.2 | 0.18 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1159 / 13366 (8.7%) | 4412 / 133660 (3.3%) | −162.0 | −159.8 | 2.63 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 539 / 13366 (4.0%) | 1089 / 133660 (0.8%) | −161.8 | −159.6 | 4.95 |
| AR SRX1067070 | LHSAR Prostate | 633 / 13366 (4.7%) | 15691 / 133660 (11.7%) | −161.3 | −159.1 | 0.40 |
| ESR1 SRX176860 | MCF-7 Breast | 404 / 13366 (3.0%) | 12193 / 133660 (9.1%) | −161.1 | −158.9 | 0.33 |
| ESR1 SRX176861 | MCF-7 Breast | 408 / 13366 (3.1%) | 12256 / 133660 (9.2%) | −161.1 | −158.8 | 0.33 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 162 / 13366 (1.2%) | 7978 / 133660 (6.0%) | −161.1 | −158.8 | 0.20 |
| JUNB SRX10119386 | MCF 10A Breast | 195 / 13366 (1.5%) | 8606 / 133660 (6.4%) | −161.0 | −158.8 | 0.23 |
| FOXA2 SRX3230382 | Hep G2 Liver | 325 / 13366 (2.4%) | 10895 / 133660 (8.2%) | −160.9 | −158.7 | 0.30 |
| MECOM SRX23677890 | HNT-34 Blood | 1532 / 13366 (11.5%) | 6854 / 133660 (5.1%) | −160.6 | −158.4 | 2.24 |
| FOXA1 SRX100506 | Hep G2 Liver | 315 / 13366 (2.4%) | 10715 / 133660 (8.0%) | −160.5 | −158.2 | 0.29 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 227 / 13366 (1.7%) | 9167 / 133660 (6.9%) | −159.9 | −157.7 | 0.25 |
| CEBPB SRX2194250 | SUM 159PT Breast | 276 / 13366 (2.1%) | 10029 / 133660 (7.5%) | −159.9 | −157.7 | 0.28 |
| ARID1A SRX5089376 | MCF-7 Breast | 182 / 13366 (1.4%) | 8323 / 133660 (6.2%) | −159.6 | −157.4 | 0.22 |
| CEBPA SRX2630241 | Hep G2 Liver | 290 / 13366 (2.2%) | 10253 / 133660 (7.7%) | −159.3 | −157.1 | 0.28 |
| FOXA1 SRX3931055 | MCF-7 Breast | 177 / 13366 (1.3%) | 8214 / 133660 (6.1%) | −159.3 | −157.1 | 0.22 |
| STAT5B SRX831881 | CD8+ T cells Blood | 242 / 13366 (1.8%) | 121 / 133660 (0.1%) | −158.8 | −156.6 | 20.00 |
| FOXA1 SRX3931054 | MCF-7 Breast | 204 / 13366 (1.5%) | 8708 / 133660 (6.5%) | −158.7 | −156.5 | 0.23 |
| ESR1 SRX371468 | MCF-7 Breast | 129 / 13366 (1.0%) | 7249 / 133660 (5.4%) | −158.6 | −156.4 | 0.18 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 304 / 13366 (2.3%) | 10468 / 133660 (7.8%) | −158.6 | −156.4 | 0.29 |
| ESR1 SRX20282960 | MCF-7 Breast | 275 / 13366 (2.1%) | 9971 / 133660 (7.5%) | −158.6 | −156.4 | 0.28 |
| FOXA1 SRX11222442 | MCF-7 Breast | 130 / 13366 (1.0%) | 7264 / 133660 (5.4%) | −158.5 | −156.3 | 0.18 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1611 / 13366 (12.1%) | 7440 / 133660 (5.6%) | −158.4 | −156.2 | 2.17 |
| CEBPB SRX150598 | IMR-90 Lung | 513 / 13366 (3.8%) | 13793 / 133660 (10.3%) | −158.3 | −156.1 | 0.37 |
| AR SRX1067066 | LHSAR Prostate | 537 / 13366 (4.0%) | 14156 / 133660 (10.6%) | −158.3 | −156.1 | 0.38 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 546 / 13366 (4.1%) | 1153 / 133660 (0.9%) | −157.4 | −155.2 | 4.74 |
| AR SRX1067067 | LHSAR Prostate | 426 / 13366 (3.2%) | 12413 / 133660 (9.3%) | −157.2 | −155.1 | 0.34 |
| FOXA2 SRX100448 | Hep G2 Liver | 261 / 13366 (2.0%) | 9685 / 133660 (7.2%) | −157.2 | −155.1 | 0.27 |
| YAP1 SRX1038945 | IMR-90 Lung | 154 / 13366 (1.2%) | 7704 / 133660 (5.8%) | −157.0 | −154.8 | 0.20 |
| ESR1 SRX20282939 | MCF-7 Breast | 276 / 13366 (2.1%) | 9923 / 133660 (7.4%) | −156.4 | −154.3 | 0.28 |
| TET2 SRX2014505 | Jurkat Blood | 2171 / 13366 (16.2%) | 11529 / 133660 (8.6%) | −156.1 | −153.9 | 1.88 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 751 / 13366 (5.6%) | 17167 / 133660 (12.8%) | −155.5 | −153.3 | 0.44 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 252 / 13366 (1.9%) | 9447 / 133660 (7.1%) | −154.7 | −152.5 | 0.27 |
| RORC SRX5359053 | HCC70 Breast | 1077 / 13366 (8.1%) | 4033 / 133660 (3.0%) | −154.4 | −152.2 | 2.67 |
| NR3C1 SRX2609664 | HASM2 Lung | 344 / 13366 (2.6%) | 10994 / 133660 (8.2%) | −154.2 | −152.0 | 0.31 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 372 / 13366 (2.8%) | 11421 / 133660 (8.5%) | −153.4 | −151.2 | 0.33 |
| FOXA1 SRX1787652 | MCF-7 Breast | 119 / 13366 (0.9%) | 6883 / 133660 (5.1%) | −153.1 | −151.0 | 0.17 |
| SMARCA4 SRX5212357 | Mel270 Others | 365 / 13366 (2.7%) | 11297 / 133660 (8.5%) | −153.0 | −150.9 | 0.32 |
| MECOM SRX23677891 | HNT-34 Blood | 1507 / 13366 (11.3%) | 6843 / 133660 (5.1%) | −152.9 | −150.7 | 2.20 |
| TEAD1 SRX3401272 | MCF-7 Breast | 160 / 13366 (1.2%) | 7697 / 133660 (5.8%) | −152.8 | −150.6 | 0.21 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 213 / 13366 (1.6%) | 8683 / 133660 (6.5%) | −152.5 | −150.3 | 0.25 |
| ZFX SRX7805372 | 293 Kidney | 1305 / 13366 (9.8%) | 5505 / 133660 (4.1%) | −152.3 | −150.2 | 2.37 |
| NR3C1 SRX2609665 | HASM2 Lung | 262 / 13366 (2.0%) | 9543 / 133660 (7.1%) | −152.1 | −150.0 | 0.27 |
| FOXA1 SRX1161203 | T-47D Breast | 151 / 13366 (1.1%) | 7506 / 133660 (5.6%) | −152.1 | −150.0 | 0.20 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1707 / 13366 (12.8%) | 8259 / 133660 (6.2%) | −151.7 | −149.5 | 2.07 |
| FOXA1 SRX1447317 | MCF-7 Breast | 135 / 13366 (1.0%) | 7171 / 133660 (5.4%) | −151.6 | −149.5 | 0.19 |
| ESR1 SRX371477 | MCF-7 Breast | 93 / 13366 (0.7%) | 6278 / 133660 (4.7%) | −151.3 | −149.1 | 0.15 |
| ERG SRX063921 | K-562 Blood | 1259 / 13366 (9.4%) | 5230 / 133660 (3.9%) | −151.1 | −149.0 | 2.41 |
| JUNB SRX8488074 | SUM 229PE Breast | 331 / 13366 (2.5%) | 10680 / 133660 (8.0%) | −151.1 | −149.0 | 0.31 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 934 / 13366 (7.0%) | 3232 / 133660 (2.4%) | −151.0 | −148.8 | 2.89 |
| PBX3 SRX190343 | SK-N-SH Neural | 542 / 13366 (4.1%) | 13960 / 133660 (10.4%) | −150.7 | −148.6 | 0.39 |
| EP300 SRX2194266 | SUM 159PT Breast | 450 / 13366 (3.4%) | 12564 / 133660 (9.4%) | −150.7 | −148.5 | 0.36 |
| Epitope tags DRX443510 | 293 Kidney | 1219 / 13366 (9.1%) | 4986 / 133660 (3.7%) | −150.5 | −148.3 | 2.44 |
| ESR1 SRX10365536 | MCF-7 Breast | 104 / 13366 (0.8%) | 6488 / 133660 (4.9%) | −150.2 | −148.1 | 0.16 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 248 / 13366 (1.9%) | 9237 / 133660 (6.9%) | −150.1 | −147.9 | 0.27 |
| SMARCA4 SRX5212362 | Mel270 Others | 449 / 13366 (3.4%) | 12511 / 133660 (9.4%) | −149.7 | −147.6 | 0.36 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 266 / 13366 (2.0%) | 9533 / 133660 (7.1%) | −149.6 | −147.5 | 0.28 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 499 / 13366 (3.7%) | 13269 / 133660 (9.9%) | −149.4 | −147.3 | 0.38 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 211 / 13366 (1.6%) | 8554 / 133660 (6.4%) | −149.4 | −147.3 | 0.25 |
| ESR1 SRX1531791 | MCF-7 Breast | 235 / 13366 (1.8%) | 8978 / 133660 (6.7%) | −149.2 | −147.1 | 0.26 |
| FOXA1 SRX1787651 | MCF-7 Breast | 113 / 13366 (0.8%) | 6634 / 133660 (5.0%) | −148.7 | −146.6 | 0.17 |
| AR SRX9469988 | LAPC-4 Prostate | 334 / 13366 (2.5%) | 10648 / 133660 (8.0%) | −148.6 | −146.5 | 0.31 |
| FOXA1 SRX028634 | MCF-7 Breast | 95 / 13366 (0.7%) | 6251 / 133660 (4.7%) | −148.6 | −146.5 | 0.15 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 449 / 13366 (3.4%) | 12469 / 133660 (9.3%) | −148.5 | −146.4 | 0.36 |
| PRRX1 SRX15235713 | Hs 578T Breast | 303 / 13366 (2.3%) | 10125 / 133660 (7.6%) | −148.4 | −146.3 | 0.30 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1042 / 13366 (7.8%) | 3915 / 133660 (2.9%) | −148.3 | −146.2 | 2.66 |
| AR SRX10820651 | LNCAP Prostate | 295 / 13366 (2.2%) | 282 / 133660 (0.2%) | −147.7 | −145.6 | 10.46 |
| FOXA1 SRX15430999 | T-47D Breast | 271 / 13366 (2.0%) | 9559 / 133660 (7.2%) | −147.7 | −145.6 | 0.28 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 144 / 13366 (1.1%) | 7228 / 133660 (5.4%) | −147.4 | −145.3 | 0.20 |
| RORC SRX5359052 | HCC70 Breast | 1088 / 13366 (8.1%) | 4214 / 133660 (3.2%) | −147.3 | −145.2 | 2.58 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 321 / 13366 (2.4%) | 10379 / 133660 (7.8%) | −147.0 | −144.9 | 0.31 |
| FOXA1 SRX1961157 | T-47D Breast | 262 / 13366 (2.0%) | 9381 / 133660 (7.0%) | −147.0 | −144.9 | 0.28 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 209 / 13366 (1.6%) | 8443 / 133660 (6.3%) | −147.0 | −144.9 | 0.25 |
| CXXC1 SRX1424886 | SEM Blood | 1202 / 13366 (9.0%) | 4942 / 133660 (3.7%) | −146.8 | −144.7 | 2.43 |
| FOXA1 SRX1787655 | MCF-7 Breast | 94 / 13366 (0.7%) | 6173 / 133660 (4.6%) | −146.7 | −144.6 | 0.15 |
| FOXA1 SRX1961158 | T-47D Breast | 237 / 13366 (1.8%) | 8930 / 133660 (6.7%) | −146.4 | −144.4 | 0.27 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 223 / 13366 (1.7%) | 8676 / 133660 (6.5%) | −146.3 | −144.2 | 0.26 |
| JUN SRX6582163 | BJ-5ta Epidermis | 319 / 13366 (2.4%) | 10317 / 133660 (7.7%) | −146.2 | −144.1 | 0.31 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 518 / 13366 (3.9%) | 13433 / 133660 (10.1%) | −146.0 | −143.9 | 0.39 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 187 / 13366 (1.4%) | 8005 / 133660 (6.0%) | −145.8 | −143.7 | 0.23 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 233 / 13366 (1.7%) | 8835 / 133660 (6.6%) | −145.8 | −143.7 | 0.26 |
| FOXA1 SRX3923517 | MCF-7 Breast | 158 / 13366 (1.2%) | 7446 / 133660 (5.6%) | −145.5 | −143.4 | 0.21 |
| WWTR1 SRX10119378 | MCF 10A Breast | 267 / 13366 (2.0%) | 9421 / 133660 (7.0%) | −145.5 | −143.4 | 0.28 |
| CEBPB SRX190345 | MCF-7 Breast | 178 / 13366 (1.3%) | 7826 / 133660 (5.9%) | −145.4 | −143.3 | 0.23 |
| FOXA1 SRX219284 | LNCAP Prostate | 344 / 13366 (2.6%) | 10702 / 133660 (8.0%) | −145.4 | −143.3 | 0.32 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 233 / 13366 (1.7%) | 8823 / 133660 (6.6%) | −145.3 | −143.2 | 0.26 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1373 / 13366 (10.3%) | 6094 / 133660 (4.6%) | −145.3 | −143.2 | 2.25 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 146 / 13366 (1.1%) | 7205 / 133660 (5.4%) | −145.1 | −143.1 | 0.20 |
| ARID1A SRX5089379 | MCF-7 Breast | 237 / 13366 (1.8%) | 8888 / 133660 (6.6%) | −145.1 | −143.0 | 0.27 |
| MethylCap SRX014767 | NB-4 Blood | 1429 / 13366 (10.7%) | 6477 / 133660 (4.8%) | −145.1 | −143.0 | 2.21 |
| NR3C1 SRX2609666 | HASM2 Lung | 233 / 13366 (1.7%) | 8812 / 133660 (6.6%) | −145.0 | −142.9 | 0.26 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 233 / 13366 (1.7%) | 8815 / 133660 (6.6%) | −145.0 | −142.9 | 0.26 |
| NR3C1 SRX2609662 | HASM2 Lung | 302 / 13366 (2.3%) | 9992 / 133660 (7.5%) | −144.9 | −142.8 | 0.30 |
| GATA3 SRX6712581 | MCF-7 Breast | 197 / 13366 (1.5%) | 8156 / 133660 (6.1%) | −144.7 | −142.7 | 0.24 |
| FOXA1 SRX190181 | A549 Lung | 167 / 13366 (1.2%) | 7594 / 133660 (5.7%) | −144.7 | −142.6 | 0.22 |
| RBFOX2 SRX3322781 | K-562 Blood | 1641 / 13366 (12.3%) | 7958 / 133660 (6.0%) | −144.6 | −142.5 | 2.06 |
| JUNB SRX10119383 | MCF 10A Breast | 158 / 13366 (1.2%) | 7422 / 133660 (5.6%) | −144.5 | −142.5 | 0.21 |
| MED1 SRX5236336 | HUVEC Cardiovascular | 462 / 13366 (3.5%) | 891 / 133660 (0.7%) | −144.4 | −142.3 | 5.19 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 668 / 13366 (5.0%) | 1855 / 133660 (1.4%) | −144.3 | −142.2 | 3.60 |
| CTCF SRX10975999 | NALM-6 Blood | 2545 / 13366 (19.0%) | 14759 / 133660 (11.0%) | −144.1 | −142.1 | 1.72 |
| JUNB SRX8488089 | SUM 229PE Breast | 251 / 13366 (1.9%) | 9096 / 133660 (6.8%) | −144.0 | −142.0 | 0.28 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 195 / 13366 (1.5%) | 8098 / 133660 (6.1%) | −144.0 | −141.9 | 0.24 |
| MAU2 SRX15710550 | Fibroblasts Others | 436 / 13366 (3.3%) | 12102 / 133660 (9.1%) | −143.8 | −141.7 | 0.36 |
| SMARCA4 SRX5212371 | Mel270 Others | 369 / 13366 (2.8%) | 11051 / 133660 (8.3%) | −143.7 | −141.7 | 0.33 |
| NKX2-1 SRX2164786 | A549 Lung | 437 / 13366 (3.3%) | 12114 / 133660 (9.1%) | −143.6 | −141.6 | 0.36 |
| JUN SRX6582172 | Fibroblasts Others | 342 / 13366 (2.6%) | 10607 / 133660 (7.9%) | −143.6 | −141.5 | 0.32 |
| FOSL2 SRX190296 | SK-N-SH Neural | 350 / 13366 (2.6%) | 10728 / 133660 (8.0%) | −143.3 | −141.3 | 0.33 |
| FOXA1 SRX028635 | MCF-7 Breast | 99 / 13366 (0.7%) | 6186 / 133660 (4.6%) | −143.3 | −141.2 | 0.16 |
| ESR1 SRX20282972 | MCF-7 Breast | 290 / 13366 (2.2%) | 9733 / 133660 (7.3%) | −143.0 | −140.9 | 0.30 |
| FOXA1 SRX3923518 | MCF-7 Breast | 153 / 13366 (1.1%) | 7270 / 133660 (5.4%) | −142.7 | −140.7 | 0.21 |
| FOXA1 SRX5323843 | MCF-7 Breast | 107 / 13366 (0.8%) | 6335 / 133660 (4.7%) | −142.5 | −140.5 | 0.17 |
| STAT3 SRX150479 | MCF 10A Breast | 233 / 13366 (1.7%) | 8736 / 133660 (6.5%) | −142.5 | −140.5 | 0.27 |
| ESR1 SRX194569 | MCF-7 Breast | 272 / 13366 (2.0%) | 9392 / 133660 (7.0%) | −142.0 | −139.9 | 0.29 |
| FOXA1 SRX190282 | A549 Lung | 162 / 13366 (1.2%) | 7416 / 133660 (5.5%) | −141.9 | −139.8 | 0.22 |
| EP300 SRX100540 | SK-N-SH Neural | 386 / 13366 (2.9%) | 11256 / 133660 (8.4%) | −141.9 | −139.8 | 0.34 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 476 / 13366 (3.6%) | 12631 / 133660 (9.5%) | −141.4 | −139.3 | 0.38 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 244 / 13366 (1.8%) | 8887 / 133660 (6.6%) | −141.3 | −139.2 | 0.27 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1280 / 13366 (9.6%) | 5556 / 133660 (4.2%) | −141.2 | −139.2 | 2.30 |
| FOXA1 SRX3923519 | MCF-7 Breast | 135 / 13366 (1.0%) | 6871 / 133660 (5.1%) | −141.2 | −139.2 | 0.20 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 147 / 13366 (1.1%) | 7106 / 133660 (5.3%) | −141.1 | −139.1 | 0.21 |
| ESR1 SRX20282954 | MCF-7 Breast | 287 / 13366 (2.1%) | 9616 / 133660 (7.2%) | −141.1 | −139.0 | 0.30 |
| FOXA1 SRX3923516 | MCF-7 Breast | 168 / 13366 (1.3%) | 7507 / 133660 (5.6%) | −141.0 | −139.0 | 0.22 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 233 / 13366 (1.7%) | 8691 / 133660 (6.5%) | −141.0 | −139.0 | 0.27 |
| FOXA1 SRX11222438 | MCF-7 Breast | 116 / 13366 (0.9%) | 6476 / 133660 (4.8%) | −140.7 | −138.7 | 0.18 |
| FOS SRX3322636 | MCF-7 Breast | 153 / 13366 (1.1%) | 7206 / 133660 (5.4%) | −140.5 | −138.5 | 0.21 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 482 / 13366 (3.6%) | 12693 / 133660 (9.5%) | −140.5 | −138.5 | 0.38 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 229 / 13366 (1.7%) | 8599 / 133660 (6.4%) | −140.5 | −138.5 | 0.27 |
| ESR1 SRX2943591 | MCF-7 Breast | 168 / 13366 (1.3%) | 7487 / 133660 (5.6%) | −140.4 | −138.4 | 0.22 |
| FOXA1 SRX3931033 | MCF-7 Breast | 143 / 13366 (1.1%) | 6999 / 133660 (5.2%) | −140.2 | −138.1 | 0.20 |
| CEBPB SRX2194249 | SUM 159PT Breast | 246 / 13366 (1.8%) | 8889 / 133660 (6.7%) | −140.1 | −138.1 | 0.28 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 234 / 13366 (1.8%) | 8676 / 133660 (6.5%) | −140.1 | −138.1 | 0.27 |
| JUN SRX7277180 | GM07492 Others | 205 / 13366 (1.5%) | 8155 / 133660 (6.1%) | −139.8 | −137.8 | 0.25 |
| FOXA1 SRX9604647 | LNCAP Prostate | 404 / 13366 (3.0%) | 11465 / 133660 (8.6%) | −139.7 | −137.7 | 0.35 |
| SSRP1 SRX3436567 | HT-1080 Bone | 343 / 13366 (2.6%) | 467 / 133660 (0.3%) | −139.6 | −137.6 | 7.34 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 198 / 13366 (1.5%) | 8013 / 133660 (6.0%) | −139.4 | −137.4 | 0.25 |
| TEAD1 SRX716558 | SF268 Neural | 106 / 13366 (0.8%) | 6219 / 133660 (4.7%) | −139.1 | −137.1 | 0.17 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 126 / 13366 (0.9%) | 6625 / 133660 (5.0%) | −138.8 | −136.8 | 0.19 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 223 / 13366 (1.7%) | 8439 / 133660 (6.3%) | −138.7 | −136.7 | 0.26 |
| CEBPA SRX4705113 | MOLM-13 Blood | 646 / 13366 (4.8%) | 15032 / 133660 (11.2%) | −138.7 | −136.7 | 0.43 |
| ESR1 SRX10365532 | MCF-7 Breast | 117 / 13366 (0.9%) | 6437 / 133660 (4.8%) | −138.7 | −136.7 | 0.18 |
| FOXL2 SRX6957477 | KGN Gonad | 268 / 13366 (2.0%) | 9219 / 133660 (6.9%) | −138.6 | −136.6 | 0.29 |
| FOXA1 SRX5323829 | T-47D Breast | 121 / 13366 (0.9%) | 6511 / 133660 (4.9%) | −138.5 | −136.5 | 0.19 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 104 / 13366 (0.8%) | 6158 / 133660 (4.6%) | −138.4 | −136.4 | 0.17 |
| ESR1 SRX371467 | MCF-7 Breast | 280 / 13366 (2.1%) | 9412 / 133660 (7.0%) | −138.4 | −136.4 | 0.30 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 269 / 13366 (2.0%) | 9220 / 133660 (6.9%) | −138.1 | −136.1 | 0.29 |
| STAT3 SRX150630 | MCF 10A Breast | 238 / 13366 (1.8%) | 8674 / 133660 (6.5%) | −137.7 | −135.7 | 0.27 |
| TP53 SRX19538272 | U2OS Bone | 458 / 13366 (3.4%) | 924 / 133660 (0.7%) | −137.5 | −135.5 | 4.96 |
| JUNB SRX10119384 | MCF 10A Breast | 143 / 13366 (1.1%) | 6923 / 133660 (5.2%) | −137.5 | −135.5 | 0.21 |
| FOXA1 SRX3931056 | MCF-7 Breast | 132 / 13366 (1.0%) | 6703 / 133660 (5.0%) | −137.5 | −135.5 | 0.20 |
| TLE3 SRX4815192 | MCF-7 Breast | 228 / 13366 (1.7%) | 8490 / 133660 (6.4%) | −137.4 | −135.4 | 0.27 |
| MEN1 SRX11712604 | K-562 Blood | 1153 / 13366 (8.6%) | 4797 / 133660 (3.6%) | −137.4 | −135.4 | 2.40 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 360 / 13366 (2.7%) | 10685 / 133660 (8.0%) | −137.3 | −135.3 | 0.34 |
| VGLL1 SRX18013277 | FULVR Breast | 86 / 13366 (0.6%) | 5737 / 133660 (4.3%) | −137.2 | −135.2 | 0.15 |
| ESR1 SRX371475 | BT-474 Breast | 113 / 13366 (0.8%) | 6311 / 133660 (4.7%) | −137.2 | −135.2 | 0.18 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1291 / 13366 (9.7%) | 5711 / 133660 (4.3%) | −137.1 | −135.1 | 2.26 |
| ESR1 SRX20282946 | MCF-7 Breast | 138 / 13366 (1.0%) | 6807 / 133660 (5.1%) | −137.0 | −135.0 | 0.20 |
| JUND SRX150408 | HeLa Uterus | 222 / 13366 (1.7%) | 8366 / 133660 (6.3%) | −136.8 | −134.8 | 0.27 |
| FOXA1 SRX100477 | Hep G2 Liver | 302 / 13366 (2.3%) | 9724 / 133660 (7.3%) | −136.7 | −134.7 | 0.31 |
| STAT3 SRX2020842 | HCC70 Breast | 492 / 13366 (3.7%) | 12700 / 133660 (9.5%) | −136.6 | −134.6 | 0.39 |
| JUND SRX190357 | SK-N-SH Neural | 341 / 13366 (2.6%) | 10346 / 133660 (7.7%) | −136.3 | −134.3 | 0.33 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 237 / 13366 (1.8%) | 8606 / 133660 (6.4%) | −136.1 | −134.1 | 0.28 |
| KAT7 DRX234808 | 293 Kidney | 657 / 13366 (4.9%) | 1887 / 133660 (1.4%) | −136.1 | −134.1 | 3.48 |
| FOXA1 SRX1447316 | MCF-7 Breast | 88 / 13366 (0.7%) | 5749 / 133660 (4.3%) | −136.0 | −134.1 | 0.15 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 394 / 13366 (2.9%) | 11180 / 133660 (8.4%) | −136.0 | −134.0 | 0.35 |
| FOXA1 SRX3923515 | MCF-7 Breast | 127 / 13366 (1.0%) | 6560 / 133660 (4.9%) | −135.8 | −133.9 | 0.19 |
| FOXA1 SRX3931032 | MCF-7 Breast | 130 / 13366 (1.0%) | 6619 / 133660 (5.0%) | −135.8 | −133.8 | 0.20 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 540 / 13366 (4.0%) | 13381 / 133660 (10.0%) | −135.7 | −133.7 | 0.40 |
| FOXA1 SRX6878603 | LNCAP Prostate | 292 / 13366 (2.2%) | 9523 / 133660 (7.1%) | −135.7 | −133.7 | 0.31 |
| RBM22 SRX4708083 | K-562 Blood | 771 / 13366 (5.8%) | 2512 / 133660 (1.9%) | −135.5 | −133.5 | 3.07 |
| FOXA1 SRX1161205 | T-47D Breast | 118 / 13366 (0.9%) | 6365 / 133660 (4.8%) | −135.4 | −133.4 | 0.19 |
| FOSL2 SRX190204 | A549 Lung | 260 / 13366 (1.9%) | 8975 / 133660 (6.7%) | −135.2 | −133.3 | 0.29 |
| GRHL3 SRX2582162 | NHEK Epidermis | 877 / 13366 (6.6%) | 3131 / 133660 (2.3%) | −134.8 | −132.9 | 2.80 |
| STAT1 SRX23678708 | K-562 Blood | 1224 / 13366 (9.2%) | 5310 / 133660 (4.0%) | −134.8 | −132.8 | 2.31 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 179 / 13366 (1.3%) | 7503 / 133660 (5.6%) | −134.1 | −132.1 | 0.24 |
| FOXA1 SRX5323830 | T-47D Breast | 137 / 13366 (1.0%) | 6697 / 133660 (5.0%) | −133.8 | −131.8 | 0.20 |
| GATA3 SRX5457550 | MCF-7 Breast | 300 / 13366 (2.2%) | 9597 / 133660 (7.2%) | −133.8 | −131.8 | 0.31 |
| JADE3 DRX300415 | 293 Kidney | 1221 / 13366 (9.1%) | 5314 / 133660 (4.0%) | −133.7 | −131.7 | 2.30 |
| CEBPB SRX7807101 | Unclassified Unclassified | 189 / 13366 (1.4%) | 7660 / 133660 (5.7%) | −133.2 | −131.3 | 0.25 |
| ESR1 SRX10365535 | MCF-7 Breast | 209 / 13366 (1.6%) | 8018 / 133660 (6.0%) | −133.1 | −131.1 | 0.26 |
| STAT3 SRX150536 | MCF 10A Breast | 300 / 13366 (2.2%) | 9567 / 133660 (7.2%) | −132.9 | −131.0 | 0.31 |
| NR3C1 SRX2609659 | HASM2 Lung | 316 / 13366 (2.4%) | 9814 / 133660 (7.3%) | −132.5 | −130.6 | 0.32 |
| EP300 SRX176885 | MCF-7 Breast | 122 / 13366 (0.9%) | 6361 / 133660 (4.8%) | −132.5 | −130.6 | 0.19 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 254 / 13366 (1.9%) | 224 / 133660 (0.2%) | −132.5 | −130.5 | 11.34 |
| ARID1A SRX5089391 | MCF-7 Breast | 128 / 13366 (1.0%) | 6479 / 133660 (4.8%) | −132.4 | −130.5 | 0.20 |
| AR SRX1067068 | LHSAR Prostate | 328 / 13366 (2.5%) | 10005 / 133660 (7.5%) | −132.4 | −130.4 | 0.33 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 113 / 13366 (0.8%) | 6157 / 133660 (4.6%) | −131.8 | −129.8 | 0.18 |
| ESR1 SRX371474 | BT-474 Breast | 105 / 13366 (0.8%) | 5993 / 133660 (4.5%) | −131.7 | −129.8 | 0.18 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 391 / 13366 (2.9%) | 10977 / 133660 (8.2%) | −131.6 | −129.7 | 0.36 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 221 / 13366 (1.7%) | 8168 / 133660 (6.1%) | −131.1 | −129.2 | 0.27 |
| Epitope tags SRX15939724 | RD Muscle | 226 / 13366 (1.7%) | 8253 / 133660 (6.2%) | −131.1 | −129.1 | 0.27 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 290 / 13366 (2.2%) | 9340 / 133660 (7.0%) | −131.0 | −129.1 | 0.31 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 878 / 13366 (6.6%) | 3199 / 133660 (2.4%) | −130.7 | −128.8 | 2.74 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 829 / 13366 (6.2%) | 17255 / 133660 (12.9%) | −130.7 | −128.7 | 0.48 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1217 / 13366 (9.1%) | 5347 / 133660 (4.0%) | −130.6 | −128.7 | 2.28 |
| RBFOX2 SRX3322782 | K-562 Blood | 1513 / 13366 (11.3%) | 7382 / 133660 (5.5%) | −130.6 | −128.7 | 2.05 |
| FOXA1 SRX5203303 | MCF-7 Breast | 67 / 13366 (0.5%) | 5130 / 133660 (3.8%) | −130.6 | −128.7 | 0.13 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 239 / 13366 (1.8%) | 8462 / 133660 (6.3%) | −130.5 | −128.6 | 0.28 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 496 / 13366 (3.7%) | 12535 / 133660 (9.4%) | −130.5 | −128.6 | 0.40 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 714 / 13366 (5.3%) | 2261 / 133660 (1.7%) | −130.4 | −128.4 | 3.16 |
| FOXA1 SRX2642368 | VCaP Prostate | 334 / 13366 (2.5%) | 10029 / 133660 (7.5%) | −130.3 | −128.3 | 0.33 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 176 / 13366 (1.3%) | 7326 / 133660 (5.5%) | −130.1 | −128.1 | 0.24 |
| ESR1 SRX4367192 | MCF-7 Breast | 583 / 13366 (4.4%) | 13789 / 133660 (10.3%) | −129.9 | −128.0 | 0.42 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 162 / 13366 (1.2%) | 7060 / 133660 (5.3%) | −129.9 | −128.0 | 0.23 |
| KMT2A SRX2281249 | SEM Blood | 1550 / 13366 (11.6%) | 7661 / 133660 (5.7%) | −129.9 | −128.0 | 2.02 |
| CEBPB SRX2194248 | SUM 159PT Breast | 195 / 13366 (1.5%) | 7659 / 133660 (5.7%) | −129.7 | −127.8 | 0.25 |
| ESR1 SRX2943589 | MCF-7 Breast | 122 / 13366 (0.9%) | 6277 / 133660 (4.7%) | −129.5 | −127.6 | 0.19 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 75 / 13366 (0.6%) | 5280 / 133660 (4.0%) | −129.5 | −127.5 | 0.14 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1289 / 13366 (9.6%) | 5857 / 133660 (4.4%) | −129.4 | −127.5 | 2.20 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 188 / 13366 (1.4%) | 7524 / 133660 (5.6%) | −129.4 | −127.5 | 0.25 |
| Epitope tags SRX2867680 | 293 Kidney | 1651 / 13366 (12.4%) | 8402 / 133660 (6.3%) | −129.4 | −127.4 | 1.97 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 171 / 13366 (1.3%) | 7210 / 133660 (5.4%) | −129.2 | −127.3 | 0.24 |
| FOXA1 SRX219285 | LNCAP Prostate | 250 / 13366 (1.9%) | 8606 / 133660 (6.4%) | −129.1 | −127.2 | 0.29 |
| ARID1A SRX5089385 | MCF-7 Breast | 187 / 13366 (1.4%) | 7494 / 133660 (5.6%) | −129.0 | −127.1 | 0.25 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 374 / 13366 (2.8%) | 10615 / 133660 (7.9%) | −128.9 | −127.0 | 0.35 |
| FOXA1 SRX2017929 | LNCAP Prostate | 363 / 13366 (2.7%) | 10445 / 133660 (7.8%) | −128.9 | −127.0 | 0.35 |
| EP300 SRX1012648 | MCF-7 Breast | 111 / 13366 (0.8%) | 6033 / 133660 (4.5%) | −128.9 | −127.0 | 0.18 |
| ESR1 SRX330070 | MCF-7 Breast | 123 / 13366 (0.9%) | 6275 / 133660 (4.7%) | −128.8 | −126.9 | 0.20 |
| CDK9 SRX7366783 | MCF-7 Breast | 207 / 13366 (1.5%) | 121 / 133660 (0.1%) | −128.7 | −126.8 | 17.11 |
| Epitope tags SRX7276677 | 293 Kidney | 2108 / 13366 (15.8%) | 11847 / 133660 (8.9%) | −128.4 | −126.5 | 1.78 |
| EP300 SRX717859 | HeLa Uterus | 127 / 13366 (1.0%) | 6341 / 133660 (4.7%) | −128.3 | −126.4 | 0.20 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 261 / 13366 (2.0%) | 8765 / 133660 (6.6%) | −128.3 | −126.4 | 0.30 |
| Epitope tags SRX2745846 | MCF 10A Breast | 164 / 13366 (1.2%) | 7050 / 133660 (5.3%) | −128.2 | −126.3 | 0.23 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 231 / 13366 (1.7%) | 8249 / 133660 (6.2%) | −128.2 | −126.3 | 0.28 |
| HMG20A SRX2630163 | Hep G2 Liver | 143 / 13366 (1.1%) | 6641 / 133660 (5.0%) | −127.9 | −126.0 | 0.22 |
| CDK9 SRX7366781 | MCF-7 Breast | 200 / 13366 (1.5%) | 108 / 133660 (0.1%) | −127.9 | −126.0 | 18.52 |
| TET2 SRX1427029 | 293 Kidney | 1029 / 13366 (7.7%) | 4178 / 133660 (3.1%) | −127.8 | −125.9 | 2.46 |
| CEBPB SRX3584202 | Epididymis Gonad | 252 / 13366 (1.9%) | 8592 / 133660 (6.4%) | −127.8 | −125.9 | 0.29 |
| JUN SRX6582164 | BJ-5ta Epidermis | 356 / 13366 (2.7%) | 10288 / 133660 (7.7%) | −127.5 | −125.6 | 0.35 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 320 / 13366 (2.4%) | 9708 / 133660 (7.3%) | −127.5 | −125.6 | 0.33 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 523 / 13366 (3.9%) | 12825 / 133660 (9.6%) | −127.5 | −125.6 | 0.41 |
| RELA SRX5938177 | FaDu Others | 256 / 13366 (1.9%) | 8650 / 133660 (6.5%) | −127.3 | −125.4 | 0.30 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 328 / 13366 (2.5%) | 9826 / 133660 (7.4%) | −127.1 | −125.2 | 0.33 |
| FOXA1 SRX6878604 | LNCAP Prostate | 217 / 13366 (1.6%) | 7967 / 133660 (6.0%) | −127.1 | −125.2 | 0.27 |
| ESR1 SRX2881000 | MCF-7 Breast | 239 / 13366 (1.8%) | 8349 / 133660 (6.2%) | −127.0 | −125.2 | 0.29 |
| FOXA1 SRX1885181 | LNCAP Prostate | 248 / 13366 (1.9%) | 8504 / 133660 (6.4%) | −127.0 | −125.1 | 0.29 |
| ARID1A SRX5089388 | MCF-7 Breast | 121 / 13366 (0.9%) | 6183 / 133660 (4.6%) | −127.0 | −125.1 | 0.20 |
| TP53 SRX396254 | Fibroblasts Others | 700 / 13366 (5.2%) | 2227 / 133660 (1.7%) | −126.9 | −125.1 | 3.14 |
| NR3C1 SRX19024866 | MCF-7 Breast | 72 / 13366 (0.5%) | 5139 / 133660 (3.8%) | −126.8 | −124.9 | 0.14 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 321 / 13366 (2.4%) | 9702 / 133660 (7.3%) | −126.8 | −124.9 | 0.33 |
| ESR1 SRX4451213 | MCF-7 Breast | 277 / 13366 (2.1%) | 8976 / 133660 (6.7%) | −126.6 | −124.8 | 0.31 |
| JUN SRX883584 | MDA-MB-231 Breast | 454 / 13366 (3.4%) | 11767 / 133660 (8.8%) | −126.6 | −124.8 | 0.39 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 411 / 13366 (3.1%) | 806 / 133660 (0.6%) | −126.5 | −124.6 | 5.10 |
| CHD6 SRX17709200 | C4-2 Prostate | 1250 / 13366 (9.4%) | 5656 / 133660 (4.2%) | −126.4 | −124.5 | 2.21 |
| ESR1 SRX1531796 | MCF-7 Breast | 129 / 13366 (1.0%) | 6318 / 133660 (4.7%) | −126.3 | −124.4 | 0.20 |
| EP300 SRX717860 | HeLa Uterus | 164 / 13366 (1.2%) | 6991 / 133660 (5.2%) | −126.3 | −124.4 | 0.23 |
| GATA3 SRX100559 | T-47D Breast | 307 / 13366 (2.3%) | 9456 / 133660 (7.1%) | −126.3 | −124.4 | 0.32 |
| ESR1 SRX10365533 | MCF-7 Breast | 112 / 13366 (0.8%) | 5975 / 133660 (4.5%) | −126.1 | −124.2 | 0.19 |
| FOXA1 SRX6860635 | T-47D Breast | 200 / 13366 (1.5%) | 7637 / 133660 (5.7%) | −126.0 | −124.1 | 0.26 |
| PGR SRX1012655 | MCF-7 Breast | 167 / 13366 (1.2%) | 7032 / 133660 (5.3%) | −125.9 | −124.0 | 0.24 |
| ARID1A SRX5679787 | 12Z Others | 87 / 13366 (0.7%) | 5437 / 133660 (4.1%) | −125.5 | −123.7 | 0.16 |
| FOXA1 SRX1161207 | T-47D Breast | 92 / 13366 (0.7%) | 5546 / 133660 (4.1%) | −125.5 | −123.7 | 0.17 |
| ESR1 SRX2912055 | MCF-7 Breast | 89 / 13366 (0.7%) | 5474 / 133660 (4.1%) | −125.4 | −123.5 | 0.16 |
| NFYB SRX16608147 | HeLa Uterus | 220 / 13366 (1.6%) | 160 / 133660 (0.1%) | −125.4 | −123.5 | 13.75 |
| NR3C1 SRX10977357 | A549 Lung | 164 / 13366 (1.2%) | 6963 / 133660 (5.2%) | −125.4 | −123.5 | 0.24 |
| FOXA1 SRX15431000 | T-47D Breast | 218 / 13366 (1.6%) | 7924 / 133660 (5.9%) | −125.1 | −123.3 | 0.28 |
| TLE3 SRX4815194 | SUM 149PT Breast | 207 / 13366 (1.5%) | 7728 / 133660 (5.8%) | −125.1 | −123.2 | 0.27 |
| MethylCap SRX014766 | NB-4 Blood | 1241 / 13366 (9.3%) | 5622 / 133660 (4.2%) | −125.0 | −123.2 | 2.21 |
| STAT1 SRX23678707 | K-562 Blood | 1131 / 13366 (8.5%) | 4893 / 133660 (3.7%) | −124.9 | −123.0 | 2.31 |
| FOXA1 SRX1885184 | LNCAP Prostate | 258 / 13366 (1.9%) | 8602 / 133660 (6.4%) | −124.9 | −123.0 | 0.30 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 288 / 13366 (2.2%) | 9094 / 133660 (6.8%) | −124.7 | −122.9 | 0.32 |
| ESR1 SRX1012632 | MCF-7 Breast | 122 / 13366 (0.9%) | 6136 / 133660 (4.6%) | −124.7 | −122.8 | 0.20 |
| NR3C1 SRX8520802 | HCC1187 Breast | 206 / 13366 (1.5%) | 7698 / 133660 (5.8%) | −124.7 | −122.8 | 0.27 |
| ESR1 SRX20282973 | MCF-7 Breast | 350 / 13366 (2.6%) | 10090 / 133660 (7.5%) | −124.5 | −122.7 | 0.35 |
| FOXA1 SRX9604645 | LNCAP Prostate | 407 / 13366 (3.0%) | 10973 / 133660 (8.2%) | −124.5 | −122.6 | 0.37 |
| PROX1 SRX3230397 | Hep G2 Liver | 199 / 13366 (1.5%) | 7571 / 133660 (5.7%) | −124.4 | −122.6 | 0.26 |
| CEBPB SRX2194247 | SUM 159PT Breast | 230 / 13366 (1.7%) | 8107 / 133660 (6.1%) | −124.4 | −122.5 | 0.28 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 368 / 13366 (2.8%) | 10360 / 133660 (7.8%) | −124.3 | −122.4 | 0.36 |
| ING2 SRX286201 | RKO Digestive tract | 1109 / 13366 (8.3%) | 4758 / 133660 (3.6%) | −124.2 | −122.4 | 2.33 |
| NR2F2 SRX190293 | MCF-7 Breast | 293 / 13366 (2.2%) | 9161 / 133660 (6.9%) | −124.2 | −122.4 | 0.32 |
| FOXA1 SRX2642365 | VCaP Prostate | 257 / 13366 (1.9%) | 8564 / 133660 (6.4%) | −124.2 | −122.3 | 0.30 |
| MITF SRX7368255 | Hermes 3C Epidermis | 843 / 13366 (6.3%) | 17165 / 133660 (12.8%) | −124.0 | −122.2 | 0.49 |
| EP300 SRX2194265 | SUM 159PT Breast | 457 / 13366 (3.4%) | 11708 / 133660 (8.8%) | −123.8 | −122.0 | 0.39 |
| FOXA1 SRX5323845 | MCF-7 Breast | 82 / 13366 (0.6%) | 5282 / 133660 (4.0%) | −123.8 | −122.0 | 0.16 |
| CEBPB SRX4394545 | SU-DHL-1 Bone | 281 / 13366 (2.1%) | 8949 / 133660 (6.7%) | −123.7 | −121.9 | 0.31 |
| ZEB1 SRX13298925 | MCF-7 Breast | 164 / 13366 (1.2%) | 6910 / 133660 (5.2%) | −123.7 | −121.9 | 0.24 |
| CEBPB SRX4394540 | JB6 Blood | 275 / 13366 (2.1%) | 8841 / 133660 (6.6%) | −123.6 | −121.7 | 0.31 |
| CEBPA SRX097095 | U-937 Blood | 216 / 13366 (1.6%) | 7836 / 133660 (5.9%) | −123.5 | −121.6 | 0.28 |
| ESR1 SRX2881002 | MCF-7 Breast | 268 / 13366 (2.0%) | 8717 / 133660 (6.5%) | −123.3 | −121.5 | 0.31 |
| KAT7 DRX300414 | 293 Kidney | 507 / 13366 (3.8%) | 1269 / 133660 (0.9%) | −123.0 | −121.1 | 4.00 |
| NR3C1 SRX2609661 | HASM2 Lung | 320 / 13366 (2.4%) | 9553 / 133660 (7.1%) | −122.9 | −121.1 | 0.33 |
| FOXA1 SRX9604646 | LNCAP Prostate | 395 / 13366 (3.0%) | 10735 / 133660 (8.0%) | −122.9 | −121.1 | 0.37 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 219 / 13366 (1.6%) | 7873 / 133660 (5.9%) | −122.9 | −121.1 | 0.28 |
| SREBF2 SRX5359049 | HCC70 Breast | 953 / 13366 (7.1%) | 3784 / 133660 (2.8%) | −122.9 | −121.1 | 2.52 |
| ARID1A SRX5089382 | MCF-7 Breast | 185 / 13366 (1.4%) | 7270 / 133660 (5.4%) | −122.9 | −121.1 | 0.25 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 240 / 13366 (1.8%) | 8229 / 133660 (6.2%) | −122.8 | −121.0 | 0.29 |
| WWTR1 SRX10119368 | MCF 10A Breast | 190 / 13366 (1.4%) | 7353 / 133660 (5.5%) | −122.8 | −120.9 | 0.26 |
| FOXA1 SRX1885188 | LNCAP Prostate | 214 / 13366 (1.6%) | 7777 / 133660 (5.8%) | −122.7 | −120.9 | 0.28 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 189 / 13366 (1.4%) | 7334 / 133660 (5.5%) | −122.7 | −120.8 | 0.26 |
| FOXA1 SRX3931073 | MCF-7 Breast | 152 / 13366 (1.1%) | 6654 / 133660 (5.0%) | −122.5 | −120.7 | 0.23 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 1230 / 13366 (9.2%) | 5602 / 133660 (4.2%) | −122.5 | −120.7 | 2.20 |
| NR3C1 SRX10976921 | A549 Lung | 196 / 13366 (1.5%) | 7452 / 133660 (5.6%) | −122.4 | −120.6 | 0.26 |
| VGLL1 SRX18013279 | FULVR Breast | 122 / 13366 (0.9%) | 6069 / 133660 (4.5%) | −122.4 | −120.5 | 0.20 |
| FOXA1 SRX3931031 | MCF-7 Breast | 116 / 13366 (0.9%) | 5945 / 133660 (4.4%) | −122.3 | −120.5 | 0.20 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 456 / 13366 (3.4%) | 1038 / 133660 (0.8%) | −122.1 | −120.2 | 4.39 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 184 / 13366 (1.4%) | 7228 / 133660 (5.4%) | −122.1 | −120.2 | 0.25 |
| FOXA1 SRX5323846 | MCF-7 Breast | 87 / 13366 (0.7%) | 5340 / 133660 (4.0%) | −122.0 | −120.2 | 0.16 |
| AR SRX1067069 | LHSAR Prostate | 359 / 13366 (2.7%) | 10138 / 133660 (7.6%) | −122.0 | −120.2 | 0.35 |
| NR3C1 SRX17639412 | A549 Lung | 326 / 13366 (2.4%) | 9616 / 133660 (7.2%) | −121.9 | −120.1 | 0.34 |
| NABP2 SRX9523535 | HT-1080 Bone | 1087 / 13366 (8.1%) | 4662 / 133660 (3.5%) | −121.9 | −120.1 | 2.33 |
| NR3C1 SRX10977372 | A549 Lung | 157 / 13366 (1.2%) | 6718 / 133660 (5.0%) | −121.7 | −119.9 | 0.23 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 957 / 13366 (7.2%) | 3832 / 133660 (2.9%) | −121.5 | −119.7 | 2.50 |
| FOXA1 SRX497612 | VCaP Prostate | 270 / 13366 (2.0%) | 8678 / 133660 (6.5%) | −121.2 | −119.4 | 0.31 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 973 / 13366 (7.3%) | 3941 / 133660 (2.9%) | −121.2 | −119.3 | 2.47 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1783 / 13366 (13.3%) | 9593 / 133660 (7.2%) | −121.1 | −119.3 | 1.86 |
| BMI1 SRX644729 | 293 Kidney | 202 / 13366 (1.5%) | 130 / 133660 (0.1%) | −121.1 | −119.2 | 15.54 |
| ESR1 SRX330069 | MCF-7 Breast | 164 / 13366 (1.2%) | 6827 / 133660 (5.1%) | −121.0 | −119.2 | 0.24 |
| NR3C1 SRX10977373 | A549 Lung | 147 / 13366 (1.1%) | 6512 / 133660 (4.9%) | −121.0 | −119.2 | 0.23 |
| ESR1 SRX5323873 | MCF-7 Breast | 353 / 13366 (2.6%) | 10006 / 133660 (7.5%) | −120.9 | −119.1 | 0.35 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 427 / 13366 (3.2%) | 918 / 133660 (0.7%) | −120.8 | −119.0 | 4.65 |
Showing first 500 of 16632 rows.